Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” third quarter 2024 ...

In a report released on December 8, Conor McNamara from RBC Capital maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a ...

The stock's fall snapped a two-day winning streak.

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical ...

Thermo Fisher Scientific's valuation multiples offer potential capital appreciation. Learn why TMO stock is a Buy, with ...

The Thermo Fisher Scientific Junior Innovators Challenge engages 65-thousand middle school students annually through affiliate science and engineering fairs nationwide. Tina ...

Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $537.23 which represents a slight increase of $7.87 or 1.49% from the prior close of $529.36. The stock opened at ...

The US Food and Drug Administration granted clearances to tests for infectious diseases, drug resistances, and chronic diseases, among other clearances.

Discover efficient phase analysis and microstructural insights to optimize materials for aerospace, automotive, and battery applications.

This useful study highlights the largely redundant role of the decapping activators Edc3 and Scd6 in orchestrating post-transcriptional programs to modulate metabolic responses to nutrients in yeast.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the firm, ...

Thermo Fisher Scientific logged a 1.9% change during today's afternoon session, and is now trading at a price of $530.88 per ...